Abstract: Objective To investigate the effect of M 5 muscarinic receptor subtype on the locomotor sensitization induced by heroin priming, and it's effect on the FosB expression in the nucleus accumbens (NAc) and the hippocampus in the heroin sensitized rats. Methods Locomotor activity was measured every 10 min for 1 h after subcutaneous injection of heroin. FosB expression was assayed by immunohistochemistry, and the antisense oligonucleotides (AS-ONs) targeting M 5 muscarinic receptor was transferred with the lipofectin. Results Microinjection of AS-ONs targeting M 5 muscarinic receptor in the ventral tegmental area (VTA) blocked the expression of behavioral sensitization induced by heroin priming in rats. Meanwhile, the expression of FosB-positive neurons in either the NAc or the dentate gyrus (DG) of the hippocampus increased in heroin-induced locomotor sensitized rats. The enhancement of FosB-positive neurons in the NAc or DG could be inhibited by microinjection of M 5 muscarinic receptor AS-ONs into the VTA before the heroin-induced locomotor sensitization was performed. In contrast, microinjection of M 5 muscarinic receptor sense oligonucleotide (S-ONs) into the VTA did not block the expression of behavioral sensitization or the expression of FosB in the NAc or DG in the heroin sensitized rats. Conclusion Blocking M 5 muscarinic receptor in the VTA inhibits the expression of heroin-induced locomotor sensitization, which is associated with the regulation of FosB expression in the NAc and hippocampus neurons. M 5 muscarinic receptor may be a useful pharmacological target for the treatment of heroin addiction.
Introduction
Sensitization (a progressive enhancement of locomotor activity) to drugs of abuse is produced when the drugs are administered repeatedly in animals. Sensitization to morphine can be sustained for several months even after cessation of drug administration, and is thought to serve as a useful animal model of plasticity and neuroadaptation associated with repeated administration of opioids that have abuse potential. Recent studies show that sensitization has a close relationship with relapse, compulsive drug-seeking and drug-taking behaviors. In the incentive sensitization theory of addiction, it seems that sensitization plays an important role in compulsive drug-seeking behavior and relapse [1] . Therefore, investigation of sensitization may help us to better understand the relapse mechanisms and provide new strategies for the treatment of drug addiction.
Heroin-induced locomotor sensitization seems to be mediated by neuroplastic changes in the ventral tegmental area (VTA) [2] . M 5 muscarinic receptor is the most recent member of the muscarinic acetylcholine receptor family (M 1 -M 5 ) to be cloned. Interestingly, M 5 receptor mRNA has been identified as the only muscarinic receptor mRNA in dopaminecontaining neurons of both the substantia nigra and the VTA [3] . Evidence suggests that acetylcholine-dependent activation of M 5 receptors in dopamine-containing neurons of the VTA might modulate the manifestations of opiate reward and withdrawal [4] . This hypothesis has been tested in a series of behavioral, biochemical, and neurochemical studies using M 5 receptor-deficient mice (M 5 -/-mice) as experimental tools [4] . It has therefore been pro-posed that M 5 receptors may play a role in drug addiction.
Owing to lacking ligands that can selectively stimulate or inhibit the M 5 receptor, the physiological roles of this receptor subtype remained obscure. Oligonucleotides (oligos) are short DNA molecules that can be transported into neurons. Oligos could arrest the translation of new protein by hybridizing with the complementary mRNA [5] . Injecting oligos into the brain can alter the production of selected proteins and alter the behaviors consistent with the functions of those proteins.
In the present study, an antisense oligonucleotide (AS-ON) of M 5 was infused into the VTA to inhibit the M 5 receptor pruduction. The long-term neuroplastic changes as measured by the FosB protein expression in the nucleus accumbens (NAc) and the hippocampus, both of which were afferent mainly from VTA dopaminergic neurons, were examined. [6] ) relative to bregma: AP, -6.0 mm; ML, -1.0 mm; DV, -7.3 mm. Stylets constructed from 30-gauge stainless steel tubing (Plastic One Inc., VA, USA) were inserted into the guide cannulae to maintain patency. Rats were allowed to recover from the surgery for at least 5 d before drug delivery and behavioral monitoring.
Materials and methods

Animals and housing conditions
Oligos
Oligos were synthesized by Shanghai Sangon Biological Engineering Technology and Service Co., Ltd. The oligo sequences were based on a rat M 5 receptor cDNA sequence. The M 5 sense oligos was a copy of a 21-base sequence of the rat M 5 receptor gene, near the 5' end of the cDNA sequence, including the last 6 bases before the start codon and the next 15 bases in the coding region of the gene. The M 5 antisense oligos was the complement to the M 5 sense one, designed to prevent translation of the M 5 receptor protein by hybridizing with the initiation region of the mRNA transcribed from the M 5 receptor gene [5] . All oligos had modified phosphodiester backbones. The sequences were as follows: M 5 sense, 5'-GCC AGG ATG GAA GGG GAG TCT-3'; M 5 antisense, 5'-AGA CTC CCC TTC CAT CCT GGC-3'.
Drug administration and behavioral monitoring
Rats were acclimated to the activity monitor for 15 min before drug injection. Locomotor activity over a 60-min period was quantified using 8-beam infrared animal activity cages (30 × 30 × 30 cm). In the following experiments, we examined the effect of intra-VTA administration of M 5 muscarinic receptor AS-ONs on the expression of heroin-induced motor sensitization. Rats received 3 treatments during this study: 1) a subcutaneous injection of either heroin (0.25 mg/kg) or sterile saline was administered on day 1-8; 2) unilateral intra-VTA injection of M 5 muscarinic receptor AS-ONs, SONs or lipofectin was administered respectively on day 18; 3) 24 h later (day 19), one challenging injection (heroin, 0.25 mg/kg, s.c.) was administered. All intra-VTA infusions were injected unilaterally via the injection cannulae in a volume of 0.5 µL (2 µg oligos) over 2 min using a micro-infusion pump (Bioanalytical Systems Inc., USA). The injection cannulae were kept in place for 2 min after infusion to avoid any backflow.
In all experiments, after the drug treatment, rats were placed in acrylic monitoring cages, and motor activity was assessed according to the number of successive infrared beam crossings in the horizontal plane within 10-min intervals over 60 min.
Location of microinjection cannula tips
Rats underwent intracardiac perfusion (see below) immediately after activity monitoring. Brains were removed from the skull, rinsed in ice-cold PBS, and blocked on ice. The midbrain block was frozen separately and mounted in the Optimum Cutting Temperature Compound (Leica Instruments GmbH, Germany). Coronal sections through the VTA (50 µm) were obtained and Nissl stained to verify correct placement of injection cannula tips. Behavioral and neurochemical data from rats with correctly positioned VTA cannulae were incorporated into the analysis. 2.6 Immunohistochemistry Immediately after behavioral testing, the rats were deeply anaesthetized with sodium pentobarbital (60 mg/kg, i.p.) and transcardially perfused with approximately 200 mL of saline, followed by 200 mL of 4% paraformaldehyde in 0.1 mol/L PB (pH 7.4). The brains were removed, post-fixed overnight, and then stored in 30 % sucrose at 4 °C. Coronal sections (based on Paxinos and Watson, 1998 [6] ) of the NAc (30 µm; from bregma 1.7 mm to 1.5 mm) and the hippocampus (30 µm; from bregma -3.3 mm to -3.5 mm) were collected. All tissue sections used in this experiment were processed for FosB protein detection.
The sections were rinsed in 0.01 mol/L PBS (three times for 10 min each) and incubated in 0.01 mol/L PBS containing 5% normal goat serum (Vector Laboratories, USA) and 0.2% Triton X-100 (Sigma, USA) for 30 min. The sections were then incubated for 48 h at 4 °C in 0.01 mol/L PBS containing anti-FosB rabbit polyclonal antibody (1:500). The primary antibody used to recognize FosB/ΔFosB was a polyclonal rabbit antibody (H-75, sc-7203; Santa Cruz Biotechnology Inc., USA). This antibody is raised against the N-terminus of FosB molecule and thus, recognizes both FosB and different isoforms of ΔFosB. After rinsed in 0.01 mol/L PBS, the sections were incubated in 0.01 mol/L PBS containing biotinylated goat anti-rabbit IgG (1:200; Vector Laboratories, USA). The sections were rinsed again using 0.01 mol/L PBS and incubated with avidin-biotinylated peroxidase complex (ABC kit, Vector Laboratories, USA) for 1 h. The reaction was terminated by rinsing the sections in 0.01 mol/L PBS. The sections were then incubated in diaminobenzidine for 5 min. Finally, the sections were mounted onto gelatin-coated slides, dried and dehydrated before cover-slipped. FosB immunoreactivity was quantified using an Olympus Opticals (Olympus BX51, Olympus Optical Co., Japan) microscope attached to an image analysis system (Mcroimage, Olympus Optical Co.). The shape of the sampling area was varied to best conform to the structure being measured with the sampling area ranging 0.10 -0.20 mm 2 rectangle. In addition, the dentate gyrus (DG) of the hippocampus was placed in a fixed rectangle area (0.60 mm 2 ). Results for total FosB-positive (FosB+) counts were presented as mean±SEM. Statistical analysis was done by one-way ANOVA, post-hoc comparisons were conducted by using Newman-Keuls tests. P < 0.05 was considered significant.
Results
Location of microinjection cannula tips
According to the result of sections stained with cresyl violet, it indicated that infusion-cannula tip placement was located in the VTA, generally at the rostal edge of the interpedunular nucleus (Fig 1). 3.2 Drug diffusion into the VTA To examine the extent of drug diffusion and to verify that the drug was confined to the VTA, blue ink solution was microinfused unilaterally into the VTA according to the injection protocol as described previously. Coronal sections (50 µm) through the VTA were visualized under a light microscopy (data not shown). That dye indicated that the extent of diffusion was confined to the VTA over study period, suggesting that the drug would remain within the VTA.
Repeated heroin administration produces locomotor sensitization
The cumulative number of beam crossings over 60 min (mean±SEM) for each treatment day is shown in Fig. 2A . A significant increase in locomotor activity was found on day 19 compared with day 1 (P < 0.05). It suggests that this treatment produces the locomotor sensitization.
Microinjection of M 5 muscarinic receptor AS-ONs
into the VTA blocks the expression of heroin-induced locomotor sensitization Effect of M 5 muscarinic receptor on the expression of heroin-induced locomotor sensitization (Fig. 2B, C) was evaluated by comparing the treatment group (Her/M5AS/Her) with the sensitized rats (Her/Veh/ Her). In the Her/M5AS/Her group, M 5 muscarinic receptor AS-ONs treatment reduced heroin-induced locomotor ac- tivity on day 19 compared with the Her/Veh/Her group (P < 0.05, Fig. 2B ). At 10, 20, and 30 min time point, the cumulative number of locomotor activity of the Her/M5AS/Her group on day 19 were significantly lower than that of the Her/Veh/Her group (P < 0.05, Fig. 2C ). But there are no differences between the Her/M5S/Her group and the Her/ Her group (P > 0.05; Fig. 2C ). This result suggests that blocking M 5 muscarinic receptor in the VTA inhibits the expression of heroin-induced locomotor sensitization. noreactivity in the NAc and DG was examined in the rats on day 19 of treatment. Figure 4D and E is a stereotaxic illustration of a coronal section through the DG and NAc. Figure 3 illustrates the distribution pattern of FosB-positive nuclei in the shell (NAcS) and the core (NAcC) regions of the NAc. Cumulative FosB immunoreactivity from multiple subjects for each treatment group is shown in Fig. 4A, B and C.
ANOVA demonstrated significant differences in the number of FosB-positive nuclei between different drug treatment groups in the DG, NAcS and NAcC on day 19 of treatment. Post-hoc testing of individual treatment groups in the DG, NAcS and NAcC showed significant differences between treatment groups. Heroin treatment (Her/Veh/Her) produced a significant increase in the number of FosB- positive nuclei compared with rats received saline treatment (P < 0.05; Fig. 3A, B) . M 5 muscarinic receptor AS-ONs treatment significantly attenuated heroin-induced FosB immunoreactivity in the DG, NAcS and NAcC in the Her/ M5AS/Her group compared with the Her/Veh/Her group (P < 0.05; Fig. 4, Fig. 3B, C) , while the M 5 muscarinic receptor S-ONs had no effect (P > 0.05; Fig. 4, Fig. 3D, B) . The number of FosB-stained neurons in the control group (NS/ Veh/NS) was at baseline levels (data not shown).
Discussion
The finding in the present study was that the repeated heroin administration produced the sensitization of locomotor activity. The expression of sensitization induced by heroin can be blocked by microinjection of M 5 muscarinic receptor AS-ONs, but not by injection of M 5 muscarinic receptor S-ONs, into the VTA. Meanwhile, the expression of FosB in the NAc and the hippocampus could be induced by chronic treatment with heroin, and the enhancement of FosB in the NAc and the hippocampus was inhibited by blocking M 5 muscarinic receptor. The cholinergic system has been implicated in the reinforcing effect of drugs of abuse [7] . The cholinergic modulation of midbrain dopaminergic neuron activity may be mediated by the M 5 subtype of muscarinic cholinergic receptors [3, 8] . Dopaminergic VTA neurons receive cholinergic input from the lateral-dorsal tegmental (LDT) and pedunculopontine (PPT) nuclei. Infusion of M 5 receptor AS-ONs into the VTA temporarily increased brain stimulation reward thresholds in the rats [7] .
The generation of M 5 -/-mice has provided evidence that M 5 receptors facilitate striatal dopamine release. The prolonged accumbal dopamine release, observed in intact animals after electrical stimulation of the LDT, was absent in M 5 -/-mice [9] [10] [11] . The M 5 -/-mice exhibited decreased dopamine release and conditioned place preference in response to morphine and blunted withdrawal symptoms compared with wild-type mice [12] , and also decreased cocaine-conditioned place preference and cocaine self-administration in M 5 -/-mice [13, 14] . Moreover, the abuse-related effects of morphine were attenuated in the M 5 -/-mice relative to the wildtype mice, whereas morphine-induced analgesia remained unchanged [12] . The present results further support the idea that M 5 muscarinic receptors in the VTA are important for the cholinergic activation of dopamine neurons in modulating drug addiction. The analysis of immediate-early gene (IEG) expression provides a useful tool to identify the brain regions that are influenced by a particular environmental or pharmacologic treatment, and has been used extensively in studies addressing the biological bases of animals' responses to drugs of abuse [15, 16] . The various IEGs (e.g. c-fos, FosB, JunB) studied in this way are characterized by different regional sensitivities to specific stimuli as well as differing time courses of expression [17, 18] . It has been previously reported that the expression of ΔFosB and the chronic Fosrelated antigens (FRAs) that are derived from the ΔFosB protein is augmented by chronic treatment with cocaine [19] . Similarly, other drugs of abuse, as well as other types of chronic treatment, can elicit increased neuronal expression of ΔFosB [20] . Increasing evidence suggests that ΔFosB is an important transcription factor induced in the brain's reward pathways after chronic exposure to drug abuse. It appears to be a molecular switch for long-term adaptation in the brain [21, 22] . Our data showed the enhacement of FosB expression in the NAc and the hippocampus during heroin repeated administration, suggesting that the transcriptional regulation by FosB gene plays a critical role in heroin-induced behavioral responses. Here, an antibody directed against the N-terminus of the FosB (46 kDa) molecule, from which the smaller ΔFosB fragment is derived, was used in the immunohistochemical analysis to assess the chronic changes of FosB gene expression in the specific nuclei [23, 24] . The ΔFosB protein (33 kDa) and the chronic FRAs (35 -37 kDa) were not differentiated in the present experiment, both of which can be definitively identified only by using gel-electrophoresis techniques.
The mesolimbic dopamine system is thought to be involved in morphine-induced hyperactivity [25, 26] . The fibers of the NAc and the hippocampus were projected from the dopaminergic neurons of VTA. The present study demonstrated that the heroin-sensitized rats produced a significant increase in the number of FosB-positive nuclei in the DG, NAcS and NAcC. Because FosB is one of the key molecules for neural plasticity induced by chronic external stimuli [27] , the data indicate that the high level expression of FosB-positive nuclei in the DG and NAc are associated with heroin-induced sensitization in rats. The M 5 receptor is the only muscarinic acetylcholine receptor subtype detected in the dopaminergic neurons of VTA, which ascend to the NAc and the hippocampus. The present results found that infusion M 5 muscarinic receptor AS-ONs in the VTA inhibits the expression of heroin-induced locomotor sensitization, and attenuates heroin-induced FosB immunoreactivity in the DG, NAcS and NAcC. The results suggest that M 5 muscarinic receptor may exert important effect in sensitized responses to drug exposure, possibly by modulating FosB activity in postsynaptic neurons.
In conclusion, both the expression of heroin sensitization and the expression of FosB in the NAc and the hippocampus were inhibited by blocking M 5 muscarinic receptor expression in the VTA. The data provided the evidence that M 5 muscarinic receptor may represent a useful treatment target for heroin addiction.
